Overview

You're ready to work at the forefront of pharmaceutical sciences advancement. Take your education to the next level with a PhD at UBC Pharm Sci. It's where you'll work shoulder to shoulder with other world-class experts in the field of pharmaceutical sciences, contributing knowledge, developing solutions, and shaping the future of health care. Come to work every day at one of the world's most inspiring campuses, where you will find exceptional mentors and supervisors, and state-of-the-art facilities.

What makes the program unique?

At UBC Pharm Sci, our research has shaped our outstanding international reputation. This is the place to collaborate with some of the world's foremost pharmaceutical experts, generating relevant, evidence-based and industry-focused research that makes a positive impact on broader society.

At UBC, we welcome diversity. Students come to us from a wide range of educational backgrounds and home countries. More than 50% of our graduate students come from other parts of the world, including the US and countries in Asia, Africa and Europe. We offer orientation events to help new students integrate into life here in Vancouver, at UBC and within the Faculty. And our Pharmaceutical Sciences Graduate Student Society (PharGS) will make you feel right at home.

 

Quick Facts

Degree
Doctor of Philosophy
Mode of delivery
On campus
Registration options
Full-time
Specialization
Pharmaceutical Sciences
Program Components
Dissertation

Video

Program Enquiries

If you have reviewed the information on this program page and understand the requirements for this program, you may send an enquiry

Research Information

Research Highlights

Pioneering research for the first drug-eluting coronary stent was accomplished by our Faculty
The Neglected Global Diseases Initiative was developed in our Faculty. (http://ngdi.ubc.ca)
Collaboration for Outcomes Research and Evaluation was developed in the Faculty of Pharmaceutical Sciences (www.core.ubc.ca)

Research Focus

Genomics and individualized therapy. Epidemiology. Nanomedicine. Pharmacology. A MSc or PhD in pharmaceutical sciences is the entry point to countless fields of research and teaching. Graduates of UBC Pharm Sci have gone on to fine-tune treatments for diseases like tuberculosis, lecture internationally about female contraceptives, study the regulation of cardiac metabolism following diabetes, optimize medication dosages for organ transplantation, and improve mental health outcomes through a better understanding of antipsychotics.

We are developing focused Graduate Training Programs that will allow MSc and PhD students to tailor their research and educational environments to suit their needs.

Research Facilities

We moved into the new Pharmacy building in 2012 which houses modern, modular labs designed specifically for the type of research intended for the space. Our classroom facilities has been fitted with the necessary technology to facilitate new modes of learning.

The Faculty houses a modern mass spectrometer facility of pharmacokinetic and drug metabolism studies and a Sequenom Mass-ARRAY system for genotyping and DNA methylation studies.

Application Notes

To be considered for admission to the Pharm Sci MSc program, we must receive your completed application by February 15. Incomplete applications will not be considered.

Requirements

TOEFL (ibT) Overall Score Requirement

100
22
22
22
22

IELTS Overall Score Requirement

7.0
6.5
6.5
6.5
6.5

Supervisor commitment required prior to application?

No

Deadline Details

Application Deadline

Deadline to submit online application. No changes can be made to the application after submission.

Transcript Deadline

Deadline to upload scans of official transcripts through the applicant portal in support of a submitted application. Information for accessing the applicant portal will be provided after submitting an online application for admission.

Referee Deadline

Deadline for the referees identified in the application for admission to submit references. See Letters of Reference for more information.

September 2020 Intake

Application Open Date
01 October 2019
Canadian Applicants
Application Deadline: 15 February 2020
Transcript Deadline: 15 February 2020
Referee Deadline: 22 February 2020
International Applicants
Application Deadline: 15 February 2020
Transcript Deadline: 15 February 2020
Referee Deadline: 22 February 2020

Funding Sources

All (domestic and international) students accepted into our PhD program can expect to be paid approximately $23,500 per year, provided they maintain their eligibility as a UBC graduate student. This comprises what we call a "guaranteed stipend" of $21,500, plus Graduate Support Initiative funding (provided to our MSc and PhD students who do not hold external funding), which is currently approximately $2,000 per year for the first four years of the Pharmaceutical Sciences PhD program. The stipend will be paid on a semi-monthly basis in the form of a Graduate Teaching Assistantship and/or a Graduate Research Assistantship.  Please be aware that due to the high cost of living, the guaranteed stipend most likely will not be enough, therefore, we strongly suggest students also plan to have their own personal funding in addition to the stipend.

Applicants who are interested in the production, preparation, and application of nuclear isotopes for science and medicine may consider the IsoSiM program that provides additional funding and professional development opportunities. Applicants who are interested in catalysis research with a focus on programs addressing waste generation, environmental compatibility, energy efficiency, and alternative energy sources may consider the SusSyn program.

Career Outcomes

48 students graduated between 2005 and 2013. Of these, career information was obtained for 42 alumni (based on research conducted between Feb-May 2016):


RI (Research-Intensive) Faculty: typically tenure-track faculty positions (equivalent of the North American Assistant Professor, Associate Professor, and Professor positions) in PhD-granting institutions
TI (Teaching-Intensive) Faculty: typically full-time faculty positions in colleges or in institutions not granting PhDs, and teaching faculty at PhD-granting institutions
Term Faculty: faculty in term appointments (e.g. sessional lecturers, visiting assistant professors, etc.)
Sample Employers in Higher Education
University of British Columbia (5)
Roosevelt University (2)
University of Antwerp
University of Aberdeen
Memorial University of Newfoundland
University of Georgia
University of Alabama
University of California - Los Angeles
Dalhousie University
Simon Fraser University
Sample Employers Outside Higher Education
Lower Mainland Pharmacy Services (2)
DynaLIFE
STEMCELL Technologies
Ember Therapeutics
Roche
Walmart Pharmacy
Rexall
Pfizer Canada Inc.
Sanofi Pasteur
Ipsen Biopharmaceutical, Inc.
Sample Job Titles Outside Higher Education
Scientist (3)
Manager (2)
Principal Scientist
Pharmacist
Clinical Chemist
Project Leader
Pharmacy Manager
Director
Medical Scientist
CNS Medical Affairs
PhD Career Outcome Survey
You may view the full report on career outcomes of UBC PhD graduates on outcomes.grad.ubc.ca.
Disclaimer
These data represent historical employment information and do not guarantee future employment prospects for graduates of this program. They are for informational purposes only. Data were collected through either alumni surveys or internet research.
Career Options

Genomics and individualized therapy. Epidemiology. Nanomedicine. Pharmacology. A PhD in pharmaceutical sciences is the entry point to countless fields of research and teaching. Graduates of UBC Pharm Sci have gone on to fine-tune treatments for diseases like tuberculosis, lecture internationally about female contraceptives, study the regulation of cardiac metabolism following diabetes, optimize medication dosages for organ transplantation, and improve mental health outcomes through a better understanding of antipsychotics.

Alumni on Success

Tuition / Program Costs

FeesCanadian Citizen / Permanent Resident / Refugee / DiplomatInternational
Application Fee$104.00$168.25
Tuition *
Installments per year33
Tuition per installment$1,665.26$2,925.58
Tuition per year
(plus annual increase, usually 2%-5%)
$4,995.78$8,776.74
Int. Tuition Award (ITA) per year (if eligible) $3,200.00 (-)
Other Fees and Costs
Student Fees (yearly)$930.14 (approx.)
Costs of living (yearly)starting at $16,884.10 (check cost calculator)
* Regular, full-time tuition. For on-leave, extension, continuing or part time (if applicable) fees see UBC Calendar.
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. Tuition fees are reviewed annually by the UBC Board of Governors. In recent years, tuition increases have been 2% for continuing domestic students and between 2% and 5% for continuing international students. New students may see higher increases in tuition. Admitted students who defer their admission are subject to the potentially higher tuition fees for incoming students effective at the later program start date. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.

Statistical Data

Enrolment Data

 20182017201620152014
Applications5146323035
Offers58534
New registrations57412
Total enrolment3539363535

Completion Rates & Times

This program has a graduation rate of 81.82% based on 22 students admitted between 2005 - 2008. Based on 12 graduations between 2014 - 2017 the minimum time to completion is 2.66 years and the maximum time is 6.66 years with an average of 5.05 years of study. All calculations exclude leave times.
Disclaimer
Admissions data refer to all UBC Vancouver applications, offers, new registrants for each year, May to April [data updated: 22 March 2019]. Enrolment data are based on March 1 snapshots. Program completion data are only provided for datasets comprised of more than 4 individuals. Rates and times of completion depend on a number of variables (e.g. curriculum requirements, student funding), some of which may have changed in recent years for some programs [data updated: 23 September 2018].

Research Supervisors

This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.

  • Burt, Helen Mary (Nanotechnology, non-sized drug carriers, nanoparticulte drug delivery)
  • Cairns, Brian (Neuropharmacology, Oro-Facial Pain, Pain, Electrophysiology, pain mechanisms, headache, temporomandibular disorders, sex-related differences, peripheral analgesics)
  • Chang, Thomas (Drug Metabolism, Pharmacology, Nuclear Receptor, Drug-Metabolizing Enzymes, Cytochrome P450, Gene Expression, Gene Regulation)
  • Collier, Abby (Drugs in children, Drugs in pregnancy, Developmental pharmacology, Drug metabolism, Pharmacokinetics, Drug metabolism and pharmacokinetics, primarily of the phase II (conjugation) enzymes, focused on pregnancy and pediatrics)
  • Conklin, Annalijn (Chronic Diseases in Elderly, Gender Epidemiology, Health Policies, Professional Practices, Obesity, Social Determinants of Dietary and Metabolic Disorders, Community Health / Public Health, healthy ageing, obesity prevention, diabetes management and evaluation, healthcare quality improvement, implementation science, gender and health equity, nutrition-related policy and outcomes)
  • Coughtrie, Michael (Drug metabolizing enzymes)
  • De Vera, Mary (examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions.)
  • Frankel, Adam (Biological and Biochemical Mechanisms, Bioactive Molecules, Organic Molecules and Biomolecules, Proteins, protein biochemistry, arginine methylation, post-translational modifications, drug discovery, yeast, autophagy, chemical biology)
  • Giaever, Guri (Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation)
  • Grierson, David (Chemistry, disease, biochemistry)
  • Hafeli, Urs (Pharmacokinetics, Imaging, Radiotherapy, Immunotherapy, Development of Drug Delivery Systems, Radiopharmaceuticals, Radioimmunotherapy, Magnetic Targeting, Targeted Drug Delivery, Novel polymers, Nanoparticles, Microspheres, Microneedles, Bioconjugates)
  • Harrison, Mark (measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered)
  • Hedtrich, Sarah (Nanotechnologies, Structural Tissue Engineering / Biomaterials, Inflammatory Respiratory Diseases, Skin, Novel therapies for inflammatory and genetic diseases of human epithelia, Tissue regeneration, Topical drug delivery and Nanomedicine)
  • Jarvis-Selinger, Sandra Ann (Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology)
  • Karim, Ehsan (Epidemiology, Pharmacoepidemiology, Statistics and Probabilities, Data mining, Parametric and Non-Parametric Inference, Community Health / Public Health, Model Building, Computer Science and Statistics, Causal Inference, Biostatistics, Statistics, Machine Learning, Data science, Survey sampling)
  • Kumar, Ujendra (Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs)
  • Lalji, Fawziah (Pharmacoepidemiology, Infectious Diseases, Vaccination, Antibiotics and Resistance, Tuberculosis)
  • Li, Shyh-dar (drug delivery, pharmaceutics, nanomedicine, biopharmaceutics)
  • Loewen, Peter (Arrhythmia, Cardiovascular Diseases, Heart Failure, Stroke, Thrombosis and Embolism, Health Care Technologies, Professional Practices, Pharmacoepidemiology, Hematology, Decision Making, atrial fibrillation, stroke prevention therapy, pharmacy practice, knowledge translation of evidence to patient care, patient education, shared decision-making, clinical prediction rules, prediction of stroke and bleeding in atrial fibrillation patients, patient decision aids, adherence to medication, patient complexiometry, healthcare communication technologies, use of mobile technology for clinical decision-making, hospital pharmacy practice, quality of care, quality drug therapy)
  • Lynd, Larry (health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases )
  • MacLeod, Kathleen (Cardiovascular complications, diabetes )
  • McCormack, James (Knowledge translation and evidence-based practice)
  • Nislow, Corey (genomics and develops biotechnology tools to address both fundamental and applied biological questions; Parallel genome-wide chemical genomic screens; High throughput cell-based screens; Next Generation Sequencing)
  • Page, Brent (Cell Signaling and Cancer, Drug Discovery, Drug Development, Medicinal Chemistry, Chemical Biology, Cancer, Target Engagement, Cell Signaling)
  • Rodrigues, Brian (Diabetes, Cardiomyopathy, Heart Failure, Energy Metabolism, Cardiovascular metabolism, Diabetes, Endothelial cell - cardiomyocyte crosstalk, Vascular Endothelial Growth factors)

Pages

Recent Doctoral Citations

  • Dr. Nicole Tsao
    "Dr. Tsao studied the safety of treatments for autoimmune diseases when used during pregnancy. Autoimmune diseases occur more frequently in females and untreated disease results in harm to both mothers and offspring. Her research findings show that a group of medications called biologics are safe and effective treatment options during pregnancy." (November 2018)
  • Dr. Jacob Alexander Brodeur Gordon
    "Dr. Gordon studied the importance of altered cholesterol metabolism in advanced prostate cancer. His work established the critical nature of specific cholesterol metabolism proteins in driving cancer proliferation. These findings will further our understanding of cancer biology and aid in the creation of the next generation of cancer therapies." (November 2018)
  • Dr. Seungil Paik
    "Dr. Paik studied the mechanism involved in somatostatin-mediated protection against progression of Alzheimer's disease. He examined the effect of somatostatin on protecting blood brain barrier integrity and neurite stability. The findings from this research may be used in developing a novel therapeutic application in treating Alzheimer's disease." (November 2018)
  • Dr. Wei-Lun Tang
    "Many drugs exhibit poor solubility, limiting their absorption and clinical efficacy. Dr. Tang developed a novel approach using nanotechnology to formulate these drugs with improved solubility. His research work demonstrated the utilities of this approach in delivering these drugs more effectively and safely." (November 2018)
  • Dr. Shenglong Zou
    "Dr. Zou studied the relationship between somatostatin receptors and cannabinoid receptor 1 and found that these receptors exist and function in a complex. She also explored the pathological significance of such interaction in neuronal toxicity, offering a potential target for drug discovery against related neurological disorders." (May 2018)

Sample Thesis Submissions

 
 

September 2020 Intake

Application Open Date
01 October 2019
Canadian Applicant Deadline
15 February 2020
International Applicant Deadline
15 February 2020
 

Supervisor Search

 

Departments/Programs may update graduate degree program details through the Faculty & Staff portal. To update the application inquiries contact details please use this form.